Fair Trade Commission conducts on-site investigation into Daewoong Pharmaceutical for alleged ‘unfair support’ to affiliates

Reporter Kim Jisun / approved : 2023-11-01 00:50:15
  • -
  • +
  • 인쇄
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] The Fair Trade Commission has launched an on-site investigation after finding circumstantial evidence that Daewoong Pharmaceutical unfairly supported its group affiliates.

According to related industries on the 31st, the FTC sent investigators to Daewoong Pharmaceutical the previous day to secure data on unfair internal support.

The FTC has recently detected and is investigating allegations of unfair internal transactions by a number of companies in monitoring the status of internal transactions by mid-sized business groups.

The FTC also announced in its business plan at the beginning of the year that it will intensively monitor the expedient transfer of wealth for the succession of management rights, unfair support encroaching on the competitiveness of independent and small and medium-sized enterprises, and unfair support for insolvent affiliates.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Lotte Chilsung to Offer First-Ever Voluntary Retirement Program in 75 Years2025.11.07
Police Refer Former Doosan Bobcat Korea Executives to Prosecutors Over Bid-Rigging and Bribery Allegations2025.11.07
SK Group to Launch Early Year-End Executive Reshuffle; Major Layoffs Expected at SK Telecom2025.11.07
KT Accused of Concealing 2024 Malware Infection Affecting Subscriber Data; Government Probe Finds Security Failures Behind Micropayment Hacking2025.11.07
Korea’s National Pension Service Gains Strong Q3 Returns from U.S. Tech Stocks Amid Market Rally2025.11.07
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사